These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25502526)

  • 21. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of
    Nargesi S; Jafarzadeh J; Najafzadeh MJ; Nouripour-Sisakht S; Haghani I; Abastabar M; Ilkit M; Hedayati MT
    J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451946
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.
    Hagiwara S; Tamura T; Satoh K; Kamewada H; Nakano M; Shinden S; Yamaguchi H; Makimura K
    Mycopathologia; 2019 Feb; 184(1):13-21. PubMed ID: 30291485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.
    Alastruey-Izquierdo A; Cuesta I; Houbraken J; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
    Med Mycol; 2010 Feb; 48(1):97-102. PubMed ID: 19296366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Aspergillus tubingensis in a primary skin infection.
    Frías-De-León MG; Rosas-de Paz E; Arenas R; Atoche C; Duarte-Escalante E; Molina de Soschin D; Acosta-Altamirano G; Reyes-Montes MR
    J Mycol Med; 2018 Jun; 28(2):274-278. PubMed ID: 29551443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
    Siopi M; Pournaras S; Meletiadis J
    J Clin Microbiol; 2017 Jun; 55(6):1714-1719. PubMed ID: 28330883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
    Alcazar-Fuoli L; Mellado E; Alastruey-Izquierdo A; Cuenca-Estrella M; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4514-7. PubMed ID: 19635955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
    Jing R; Yang WH; Xiao M; Li Y; Zou GL; Wang CY; Li XW; Xu YC; Hsueh PR
    J Microbiol Immunol Infect; 2022 Apr; 55(2):282-290. PubMed ID: 33839057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources.
    Sabino R; Carolino E; Veríssimo C; Martinez M; Clemons KV; Stevens DA
    Med Mycol; 2016 Oct; 54(7):740-756. PubMed ID: 27143632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare/cryptic Aspergillus species infections and importance of antifungal susceptibility testing.
    Tsang CC; Tang JYM; Ye H; Xing F; Lo SKF; Xiao C; Han L; Wu AKL; Ngan AHY; Law KC; To YN; Sze DTT; Chim OHY; Hui TWS; Leung CWH; Zhu T; Yao C; Tse BPH; Lau SKP; Woo PCY
    Mycoses; 2020 Dec; 63(12):1283-1298. PubMed ID: 32918365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility.
    Siqueira JP; Sutton DA; García D; Gené J; Thomson P; Wiederhold N; Guarro J
    Fungal Biol; 2016 Nov; 120(11):1458-1467. PubMed ID: 27742099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin].
    Ozkütük A; Metin DY; Ergon C; Yücesoy M; Hilmioğlu PS
    Mikrobiyol Bul; 2007 Apr; 41(2):285-90. PubMed ID: 17682716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trailing or paradoxical growth of Aspergillus flavus exposed to caspofungin is independent of genotype.
    Hadrich I; Neji S; Makni F; Ayadi A; Elloumi M; Ranque S
    J Med Microbiol; 2014 Dec; 63(Pt 12):1584-1589. PubMed ID: 25210202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea.
    Won EJ; Shin JH; Kim SH; Choi MJ; Byun SA; Kim MN; Lee WG; Lee K; Uh Y; Shin MG; Suh SP
    Med Mycol; 2018 Jun; 56(4):501-505. PubMed ID: 28992138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.
    Fuller J; Schofield A; Jiwa S; Sand C; Jansen B; Rennie R
    J Clin Microbiol; 2010 Feb; 48(2):479-82. PubMed ID: 20007389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R; Pina-Vaz C; Rodrigues AG
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interactions of azoles and echinocandins against clinical strains of Aspergillus flavus.
    Denardi LB; Oliveira V; de Jesus FPK; Dalla-Lana BH; Santurio JM; Zanette RA; Alves SH
    Med Mycol; 2018 Nov; 56(8):1006-1011. PubMed ID: 29294129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov.
    Siqueira JP; Sutton DA; Gené J; García D; Wiederhold N; Peterson SW; Guarro J
    J Clin Microbiol; 2017 Mar; 55(3):947-958. PubMed ID: 28053212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of amphotericin B and micafungin combination against clinical isolates of Aspergillus species.
    Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
    J Chemother; 2011 Apr; 23(2):102-6. PubMed ID: 21571627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.